In terms of discontinuation, 7% (n=7) of subjects stopped tirzepatide after a mean duration of 8.29 1.98 months
doi: 10.3389/fpsyt.2022.926688 Received 22 April 2022 Accepted 16 May 2022 Published 20 June 2022 Volume 13 - 2022 Edited by Roumen Milev, Queen's University, Canada Reviewed by Julia Rucklidge, University of Canterbury, New Zealand
Mitochondrial homeostasis regulation by NAD + Mitochondria are the source of high-yield energy production through Oxphos and the ETC to generate ATP, of which levels must be maintained for cellular homeostasis
The SMA100 and SMA150 remain constructive, so the long-term trend is intact
Despite the prevalence of AUD, many individuals do not seek treatment, and the three FDA-approved medications for AUD remain underutilised
Even at the lower doses used for diabetes management (0.5-1 mg weekly), patients in the SUSTAIN clinical trials typically experienced 4-6 kg weight loss over 6-12 months